Company patents

AGBIOME, INC.

AGBIOME, INC. exhibits a surprising dual focus, with 61.5% of its portfolio in Peptides & Proteins (pharma_biotech sector) alongside its expected strong presence in Biocides & Pesticides (76.9% of portfolio). While Peptides & Proteins saw a significant 100.0% YoY growth in 2024, both core categories experienced a notable decline in 2025 (Biocides & Pesticides down 55.6% and Peptides & Proteins down 50.0%), suggesting a potential shift in patenting intensity or strategy after a period of rapid expansion.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

26 US filings (since 2023) · 6 categories · 4 themes

Patents

Showing 1-10 of 56

Page 1 of 6